N
Nuvation Bio
New York, NY
HealthSeries Bβ‘ Watchπ¦ Unicorn
Total Raised
$275M
Valuation
$1.2B
Nuvation Bio develops novel cancer therapies targeting difficult-to-treat oncology indications.
Funding Details
| Round | Series B |
| Amount | $275M |
| Valuation | $1.2B |
| Date | April 2021 |
| Stage | series-b |
| Headquarters | New York, NY |
Investors
Casdin CapitalSurveyor Capital
Signal
β‘
β‘ WatchWatch β $10-100M round